RIL
NAMS icon

Rothschild Investment LLC’s NewAmsterdam Pharma NAMS Stock Holding History

Rothschild Investment LLC’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102 Buy
+3
New +$99 ﹤0.01% 3515

Other funds holding NAMS

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Rothschild Investment LLC's NAMS Position: Q2 2026 in Review

Rothschild Investment LLC opened a new position in NewAmsterdam Pharma (NAMS) in Q2 2026: 3 shares worth $102. The stake represents ﹤0.01% of the portfolio and ranks #3515 among its holdings.

55 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Rothschild Investment LLC held 3 shares of NewAmsterdam Pharma worth $102 as of Q2 2026.
  • NewAmsterdam Pharma was a new Rothschild Investment LLC position in Q2 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3515 holding.
  • 55 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.